Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model
Licensed under
Category
Published on
Abstract
A critical barrier to the development of new cancer therapies is the lack of evidence validating the imaging methods used for patient response assessment. Our project evaluates the ability of improved image analysis techniques, e.g., tumor volume and necrosis fraction, to assess response in cancers such as HCC and Sarcoma in which RECIST is known to correlate poorly with clinical outcome.